Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
18.60
+0.50 (2.76%)
At close: Jun 15, 2026
Market Cap45.69M -19.1%
Revenue (ttm)109.49M -4.1%
Net Income4.87M -19.3%
EPS1.98 -19.3%
Shares Out 2.46M
PE Ratio9.39
Forward PEn/a
Dividend0.50 (2.69%)
Ex-Dividend DateSep 10, 2026
Volume30
Open18.60
Previous Close18.10
Day's Range18.60 - 18.60
52-Week Range17.30 - 32.00
Beta0.21
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Biogened

Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 184
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2025, Biogened's revenue was 113.11 million, an increase of 1.96% compared to the previous year's 110.93 million. Earnings were 4.94 million, a decrease of -15.11%.

Financial Statements